Naples Prognostic Score: A Novel Predictor of Survival in Patients with Triple-Negative Breast Cancer

被引:1
|
作者
Qiu, Yu [1 ,2 ]
Chen, Yan [1 ,2 ]
Shen, Haoyang [1 ,2 ]
Yan, Shuixin [1 ,2 ]
Li, Jiadi [1 ,2 ]
Wu, Weizhu [1 ,3 ]
机构
[1] Ningbo Univ, Affiliated Lihuili Hosp, Ningbo 315000, Peoples R China
[2] Ningbo Univ, Hlth Sci Ctr, Ningbo 315000, Zhejiang, Peoples R China
[3] Affiliated Lihuili Hosp, 1111 Jiangnan Rd, Ningbo 315000, Zhejiang, Peoples R China
关键词
triple-negative breast cancer; Naples prognostic score; prognostic factor; nomogram predictive model; INFLAMMATION;
D O I
10.2147/JIR.S472917
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Purpose: This study investigated the correlation between the Naples prognostic score (NPS), clinicopathological traits, and the postoperative prognoses of patients with triple-negative breast cancer (TNBC). Based on NPS, a predictive nomogram was developed to estimate the long-term survival probabilities of patients with TNBC post-surgery. Patients and Methods: We retrospectively examined the clinical records of 223 women with TNBC treated at Ningbo Medical Center, Lihuili Hospital between January 1, 2016 and December 31, 2020. Blood tests and biochemical analyses were conducted before surgery. The prognostic nutritional index (PNI), controlling nutritional status (CONUT), neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, and NPS were determined based on blood-related markers. A Kaplan-Meier survival analysis assessed the association between NPS, PNI, CONUT score, overall survival (OS), and breast cancer-specific survival (BCSS). Predictive accuracy was evaluated using the area under the receiver operating characteristic curve (AUC) and C index. The patients were randomly divided into the training and the validation group (6:4 ratio). A nomogram prediction model was developed and evaluated using the R Software for Statistical Computing (RMS) package. Results: NPS outperformed other scores in predicting inflammation outcomes. Patients with an elevated NPS had a poorer prognosis (P<0.001). Lymph node ratio (LNR), surgical method, postoperative chemotherapy, and NPS independently predicted OS, whereas M stage, LNR, and NPS independently predicted BCSS outcome. The OS and BCSS predicted by the nomogram model aligned well with the actual OS and BCSS. The decision curve analysis showed significant clinical utility for the nomogram model. Conclusion: In this study, NPS was an important prognostic indicator for patients with TNBC. The nomogram prognostic model based on NPS outperformed other prognostic scores for predicting patient prognosis. The model demonstrated a clear stratification ability for patient prognosis, which emphasized the potential benefits of early intervention for high-risk patients. Plain Language Summary: In this study, we aimed to understand how the Naples prognostic score (NPS) scoring system could predict the prognosis for patients with triple-negative breast cancer (TNBC). TNBC is a type of breast cancer that can be difficult to treat. Medical records of 223 women with TNBC were retrospectively analyzed. These women had their blood tested before surgery to check for certain markers related to nutrition and inflammation. NPS was used along with other scores to determine their accuracy in predicting survival. NPS was better at predicting outcomes than the other scores. The patients with higher NPS scores tended to have poorer outcomes. We also created a visual tool called a nomogram to help doctors predict patient outcomes based on the NPS scores. NPS can be a valuable tool for doctors treating patients with TNBC because it can help them predict how well a patient might do after surgery. This information could be used to tailor treatment plans for these patients. The nomogram provides a user-friendly way for doctors to use NPS in their practice. Overall, this study showed that NPS is a powerful tool for predicting outcomes for patients with TNBC, which could lead to better treatment decisions and improved outcomes for these patients.
引用
收藏
页码:5253 / 5269
页数:17
相关论文
共 50 条
  • [41] Association between lincRNA expression and overall survival for patients with triple-negative breast cancer
    Ping, Jie
    Huang, Shuya
    Wu, Jie
    Bao, Pingping
    Su, Timothy
    Gu, Kai
    Cai, Hui
    Guo, Xingyi
    Lipworth, Loren
    Blot, William J.
    Zheng, Wei
    Cai, Qiuyin
    Shu, Xiao-Ou
    BREAST CANCER RESEARCH AND TREATMENT, 2021, 186 (03) : 769 - 777
  • [42] β1 Integrin as a Prognostic and Predictive Marker in Triple-Negative Breast Cancer
    Yin, Hsin-Ling
    Wu, Chun-Chieh
    Lin, Chih-Hung
    Chai, Chee-Yin
    Hou, Ming-Feng
    Chang, Shu-Jyuan
    Tsai, Hung-Pei
    Hung, Wen-Chun
    Pan, Mei-Ren
    Luo, Chi-Wen
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2016, 17 (09):
  • [43] MicroRNA-493 is a prognostic factor in triple-negative breast cancer
    Yao, Ling
    Liu, Yirong
    Cao, Zhigang
    Li, Junjing
    Huang, Yanni
    Hu, Xin
    Shao, Zhiming
    CANCER SCIENCE, 2018, 109 (07) : 2294 - 2301
  • [44] Prognostic Biomarkers on a Competitive Endogenous RNA Network Reveals Overall Survival in Triple-Negative Breast Cancer
    Qin, Wenxing
    Qi, Feng
    Li, Jia
    Li, Ping
    Zang, Yuan-Sheng
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [45] The prognostic value of stem cell markers in triple-negative breast cancer
    Almasi, Szintia
    Nagy, Agnes
    Krenacs, Tibor
    Lantos, Tamas
    Zombori, Tamas
    Cserni, Gabor
    PATHOLOGY & ONCOLOGY RESEARCH, 2023, 29
  • [46] Prognostic significance of systemic immune-inflammation index in triple-negative breast cancer
    Liu, Jingxin
    Shi, Zhangzhen
    Bai, Yuansong
    Liu, Lin
    Cheng, Kailiang
    CANCER MANAGEMENT AND RESEARCH, 2019, 11 : 4471 - 4480
  • [47] Efficacy and prognostic factors of neoadjuvant chemotherapy for triple-negative breast cancer
    Ding, Feng
    Chen, Ru-Yue
    Hou, Jun
    Guo, Jing
    Dong, Tian-Yi
    WORLD JOURNAL OF CLINICAL CASES, 2022, 10 (12) : 3698 - 3708
  • [48] Prognostic Significance of Lymphocyte Infiltrate Localization in Triple-Negative Breast Cancer
    Ceprnja, Toni
    Mrklic, Ivana
    Peric Balja, Melita
    Marusic, Zlatko
    Blazicevic, Valerija
    Spagnoli, Giulio Cesare
    Juretic, Antonio
    Capkun, Vesna
    Tecic Vuger, Ana
    Vrdoljak, Eduard
    Tomic, Snjezana
    JOURNAL OF PERSONALIZED MEDICINE, 2022, 12 (06):
  • [49] A Novel Paclitaxel Derivative for Triple-Negative Breast Cancer Chemotherapy
    Liu, Yuetong
    Hong, Ge
    Mao, Lina
    Su, Zhe
    Liu, Tianjun
    Liu, Hong
    MOLECULES, 2023, 28 (09):
  • [50] Triple-negative breast cancer: new perspectives for novel therapies
    Mahamodhossen, Yashin A.
    Liu, Wei
    Rong-Rong, Zhou
    MEDICAL ONCOLOGY, 2013, 30 (03)